BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Allergy to pollen
,
Intestine
,
Nosology
,
Doxorubicin
,
KLK3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mitotic cytokinesis checkpoint
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Oral mucosa
Pharyngeal mucosa
Esophagus
Myometrium
Parotid gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Lichen
Hypervolemia
Congenital cerebellar hypoplasia
Irritable bowel syndrome
Hepatocellular dysplasia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Equilin
Nickel
2-ethylhexanol
Dihydrostreptomycin Sulfate
amitraz
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Rela
SULF1
POU4F3
HIC1
KRIT1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Affects of HSF1 Mouse Fibroblast response to Heat Shock
Glioblastoma multiforme and lower grade oligodendroglial tumors
Estrogen and estrogen receptor regulatation of expression in mesenteric arteries
Embryonic kidney 293T cells in prometaphase overexpressing Stau1
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for mitotic cytokinesis checkpoint
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel
Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel
Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ